{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:09:57Z","timestamp":1790744997320,"version":"4.1.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16fk0108112h0301, DNW15001"],"award-info":[{"award-number":["16fk0108112h0301, DNW15001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["16K19134"],"award-info":[{"award-number":["16K19134"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00496","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T09:50:06Z","timestamp":1521021006000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Type I Interferon-Independent Dendritic Cell Priming and Antitumor T Cell Activation Induced by a Mycoplasma fermentans Lipopeptide"],"prefix":"10.3389","volume":"9","author":[{"given":"Yohei","family":"Takeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Funami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Seya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"14459","DOI":"10.1194\/jlr.M023234","article-title":"Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages","volume":"96","author":"Underhill","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/IAI.67.2.760-771.1999","article-title":"Differential posttranslational processing confers intraspecies variation of a major surface lipoprotein and a macrophage-activating lipopeptide of Mycoplasma fermentans","volume":"67","author":"Calcutt","year":"1999","journal-title":"Infect Immun"},{"key":"B3","doi-asserted-by":"publisher","first-page":"12407","DOI":"10.1074\/jbc.273.20.12407","article-title":"Structural and functional properties of complement-activating protein M161Ag, a Mycoplasma fermentans gene product that induces cytokine production by human monocytes","volume":"273","author":"Matsumoto","year":"1998","journal-title":"J Biol Chem"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.4049\/jimmunol.166.4.2610","article-title":"Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by toll-like receptor 2: role of N-terminal hydrophobic portion in its multiple functions","volume":"166","author":"Nishiguchi","year":"2001","journal-title":"J Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fimmu.2012.00079","article-title":"The role of TLR2 in infection and immunity","volume":"3","author":"Oliveira-Nascimento","year":"2012","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1111\/cas.12824","article-title":"Adjuvant for vaccine immunotherapy of cancer \u2013 focusing on toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity","volume":"106","author":"Seya","year":"2015","journal-title":"Cancer Sci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1084\/jem.185.11.1951","article-title":"Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration","volume":"185","author":"M\u00fchlradt","year":"1997","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.micinf.2010.12.003","article-title":"Failure of mycoplasma lipoprotein MALP-2 to induce NK cell activation through dendritic cell TLR2","volume":"13","author":"Sawahata","year":"2011","journal-title":"Microbes Infect"},{"key":"B9","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/intimm\/13.7.933","article-title":"Discrimination of bacterial lipoproteins by toll-like receptor 6","volume":"13","author":"Takeuchi","year":"2001","journal-title":"Int Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/eji.200324511","article-title":"The toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity","volume":"34","author":"Link","year":"2004","journal-title":"Eur J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1078\/0171-2985-00234","article-title":"Synthetic mycoplasma-derived lipopeptide MALP-2 induces maturation and function of dendritic cells","volume":"207","author":"Weigt","year":"2003","journal-title":"Immunobiology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"539519","DOI":"10.1155\/2010\/539519","article-title":"Tumor antigen cross-presentation and the dendritic cell: where it all begins?","volume":"2010","author":"McDonnell","year":"2010","journal-title":"Clin Dev Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12026-012-8300-z","article-title":"The specialized roles of immature and mature dendritic cells in antigen cross-presentation","volume":"53","author":"Hopkins","year":"2012","journal-title":"Immunol Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1002\/embj.201488027","article-title":"Dendritic cell maturation: functional specialization through signaling specificity and transcriptional programming","volume":"33","author":"Dalod","year":"2014","journal-title":"EMBO J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/eji.200939790","article-title":"The synthetic TLR2 agonist BPPcysMPEG leads to efficient cross-priming against co-administered and linked antigens","volume":"40","author":"Prajeeth","year":"2010","journal-title":"Eur J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1080\/21645515.2015.1027467","article-title":"A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells","volume":"11","author":"Santone","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B17","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.4049\/jimmunol.1302850","article-title":"Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells","volume":"192","author":"Shen","year":"2014","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11523-012-0213-1","article-title":"Targeting pattern recognition receptors in cancer immunotherapy","volume":"7","author":"Goutagny","year":"2012","journal-title":"Target Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1073\/pnas.0605978104","article-title":"Antitumor NK activation induced by the toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells","volume":"104","author":"Akazawa","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.yexcr.2014.07.028","article-title":"Accumulation of cytolytic CD8+ T cells in B16-melanoma and proliferation of mature T cells in TIS21-knockout mice after T cell receptor stimulation","volume":"327","author":"Ryu","year":"2014","journal-title":"Exp Cell Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1188244","DOI":"10.1080\/2162402X.2016.1188244","article-title":"Biphasic function of TLR3 adjuvant on tumor and spleen dendritic cells promotes tumor T cell infiltration and regression in a vaccine therapy","volume":"5","author":"Azuma","year":"2016","journal-title":"Oncoimmunology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/imr.12432","article-title":"Dendritic cell maturation and cross-presentation: timing matters!","volume":"272","author":"Alloatti","year":"2016","journal-title":"Immunol Rev"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e12550","DOI":"10.1371\/journal.pone.0012550","article-title":"The peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activation","volume":"5","author":"Azuma","year":"2010","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e10250","DOI":"10.1371\/journal.pone.0010250","article-title":"Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments","volume":"5","author":"Dietrich","year":"2010","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.4049\/jimmunol.1401605","article-title":"TRAM is required for TLR2 endosomal signaling to type I IFN induction","volume":"193","author":"Stack","year":"2014","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1074\/jbc.M114.593426","article-title":"A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling","volume":"290","author":"Nilsen","year":"2015","journal-title":"J Biol Chem"},{"key":"B30","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301","author":"Yamamoto","year":"2003","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ni886","article-title":"TICAM-1, an adaptor molecule that participates in toll-like receptor 3-mediated interferon-beta induction","volume":"4","author":"Oshiumi","year":"2003","journal-title":"Nat Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.4049\/jimmunol.170.8.4102","article-title":"A subset of toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells","volume":"170","author":"Datta","year":"2003","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1016\/j.celrep.2017.05.015","article-title":"A TLR3-specific adjuvant relieves innate resistance to PD-L1 blockade without cytokine toxicity in tumor vaccine immunotherapy","volume":"19","author":"Takeda","year":"2017","journal-title":"Cell Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1084\/jem.20092140","article-title":"Human CD141 + (BDCA-3) + dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4049\/jimmunol.169.1.10","article-title":"Cutting edge: role of toll-like receptor 1 in mediating immune response to microbial lipoproteins","volume":"169","author":"Takeuchi","year":"2002","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1002\/cbic.200900242","article-title":"Lipopeptides from Staphylococcus aureus as Tlr2 ligands: prediction with mRNA expression, chemical synthesis, and immunostimulatory activities","volume":"10","author":"Fujimoto","year":"2009","journal-title":"Chembiochem"},{"key":"B39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.4049\/jimmunol.164.2.554","article-title":"Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway","volume":"164","author":"Takeuchi","year":"2000","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ni978","article-title":"Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon","volume":"4","author":"Le Bon","year":"2003","journal-title":"Nat Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"6715","DOI":"10.4049\/jimmunol.178.11.6715","article-title":"Cutting edge: TLR2 directly triggers Th1 effector functions","volume":"178","author":"Imanishi","year":"2007","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/gut.2003.026005","article-title":"Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model","volume":"53","author":"Schneider","year":"2004","journal-title":"Gut"},{"key":"B43","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/sj.bjc.6603903","article-title":"Intratumoural injection of the toll-like receptor-2\/6 agonist \u201cmacrophage-activating lipopeptide-2\u201d in patients with pancreatic carcinoma: a phase I\/II trial","volume":"97","author":"Schmidt","year":"2007","journal-title":"Br J Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.vaccine.2006.07.012","article-title":"Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups","volume":"25","author":"Chua","year":"2007","journal-title":"Vaccine"},{"key":"B45","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","article-title":"Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer","volume":"348","author":"Rizvi","year":"2015","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N Engl J Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","article-title":"Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade","volume":"351","author":"McGranahan","year":"2016","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.cell.2017.01.010","article-title":"Erratum: genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"168","author":"Hugo","year":"2017","journal-title":"Cell"},{"key":"B50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cell.2014.12.033","article-title":"Molecular and genetic properties of tumors associated with local immune cytolytic activity","volume":"160","author":"Rooney","year":"2015","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"93397","DOI":"10.1172\/jci.insight.93397","article-title":"Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer","volume":"2","author":"Sato-Kaneko","year":"2017","journal-title":"JCI Insight"},{"key":"B52","doi-asserted-by":"publisher","first-page":"E7240","DOI":"10.1073\/pnas.1608555113","article-title":"Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8 + T cells","volume":"113","author":"Wang","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B53","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.ccr.2012.08.010","article-title":"STAT3-driven upregulation of TLR2 promotes gastric tumorigenesis independent of tumor inflammation","volume":"22","author":"Tye","year":"2012","journal-title":"Cancer Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e1373231","DOI":"10.1080\/2162402X.2017.1373231","article-title":"Toll-like receptor 2 ligand and interferon-\u03b3 suppress anti-tumor T cell responses by enhancing the immunosuppressive activity of monocytic myeloid-derived suppressor cells","volume":"7","author":"Shime","year":"2017","journal-title":"Oncoimmunology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e18833","DOI":"10.1371\/journal.pone.0018833","article-title":"Tlr2-dependent induction of il-10 and foxp3+cd25+cd4+ regulatory T cells prevents effective anti-tumor immunity induced by pam2 lipopeptides in vivo","volume":"6","author":"Yamazaki","year":"2011","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1002\/ijc.28939","article-title":"Development of a dendritic cell-targeting lipopeptide as an immunoadjuvant that inhibits tumor growth without inducing local inflammation","volume":"135","author":"Akazawa","year":"2014","journal-title":"Int J Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T07:46:28Z","timestamp":1603957588000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2018.00496"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00496","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]},"article-number":"496"}}